This is a personal historical essay on meanderings
INTRODUCTION
Twenty five years ago, Tony Edwards and I pondered through the wee hours together on where we might go with our careers in physiology and medicine. He and I were both working in Earl Wood's laboratory as post docs. As was Earl's custom, we worked as a pair on a set of projects, I being the junior, for Tony had previously spent some postdoctoral years with Paul Korner in Sydney, and was a good instructor. My M.D. training and residency in Medicine was seemingly good background for the biological side of investigation, but now was the time for more hard science, and this laboratory was at the forefront in developing new technologies for applications in cardiovascular medicine. Tony's experience included not only respiratory and cardiovascular physiology, but also enough statistics to allow him to teach it in for-mal classes. We had worked enough together (3, 30, 31, 32) and were close friends, so that it was natural to share our contemplations of careers.
The physical explanations for biological events was something that appealed to us both. At that time we considered cardiac ventricular dynamics to be as well worked out as it could be without going into subcellular biophysics. (Certainly we were wrong, because a goodly number of folks have made careers out of it in the last twenty years.) We were both interested in the roles of flow and diffusion in exchange, influenced by the works, amongst others, of Leon Farhi and Herman Rahn on respiratory exchanges and of McDonald (57) on intravascular transport characteristics. Common to our interests on the heart and lung were the processes of exchange occurring between the convective media, blood or air, and the tissues. Tony went to Buffalo to spend a year with Leon Farhi (31, 32, 34) on gas exchange, then returned to Sydney to the newly founded physiology department at the University of New South Wales. His work was progressing very nicely in 1965 when cancer struck and killed him, a tragedy for his family and for us all.
I chose the heart. Earl Wood had been most supportive of our endeavours, and after Tony left for Buffalo, he encouraged me to develop further the approaches to characterizing circulatory transport characteristics that we were beginning. For this, he sent me for a few months to work with Homer Warner in his laboratory at the Latter Day Saints Hospital in Salt Lake City. Here we undertook some analyses (4, 6) of the input/output characteristics of a segment of the arterial system, attempting to describe the transport function, as we came to call the time-domain transfer function or impulse response, after Zierler (60, 85, 86) . Later on it turned out that we could apply the same approach to transport through the circulatory bed of an organ.
Originally, in 1961, it seemed appealing to think that one could extend this approach to transcapillary exchange in fairly short order. But a need for deeper analytical tools was already evident, and so in addition to the training from Warner, Dr. Wood sent me to the University of Minnesota for a year under the tutelage of Maurice Visscher, and where I took some courses in physiology and mathematics, and did some experiments with Rodney Harvey (42) on exchanges in the kidney. Following the leads of Chinard et al. (26) and Goresky (36) we first undertook the analysis of exchanges where capillary permeability was not a limitation to exchange. This approach was not adequate for the study of substances which were metabolized by the tissue, such as glucose, or even for inert substances such as sucrose, for which the capillary was a barrier, and so the mathematical development of models for capillary-tissue exchange became essential to further progress. Nor was this in a vacuum, for Eugene Renkin (69) with his continuous infusion technique, and Christian Crone (27) using pulse injections, had already proposed methods for estimating capillary permeability-surface area products in an approximate fashion. These we extended in order to account for mass balance and intraregional diffusion.
All this progressed but at a rate slower than I liked. Accounting mathematically for even the gross features of the physiological system and fitting the equations to the best data that we could acquire in our laboratory seemed to take forever. At each stage something new was required: new indicators, techniques for analyzing three beta emitters in a sample, multiple gamma counting for 6 tracers, better methods for optimizing the fits of the models to data, accounting for more barriers in the models, accounting for heterogeneity of flow within regions of the organ, and so on. Bob Safford and I even measured diffusion coefficients in heart tissue (78, 79) , and per-suaded Ed Lightfoot, Bob's thesis advisor at Wisconsin, to develop further the theory of molecular transport through water-filled pores (55) . What I had thought might be ten years of effort to "clean up" my understanding of mechanisms of transcapillary exchange has extended to over twenty. Thus, while I, in my youthful optimism, had hoped to be able to talk about whole body humoral regulation and its relationship to neural regulation of the circulatory system by 1986, that is, the whole of Claude Bernard's milieu interieure, ! can only report on a miniscule part of it. (This is a corollary to the "ignorance explosion".., the more one learns, the more one can appreciate how much more needs to be learned.) I will bring you up to date on some of our observations and analyses, limiting these to the heart, up to the point where we begin to consider the interactions between myocytes, endothelial ceils, and smooth muscle ceils in this simple, apparently monofunctional organ. The machete is the microtome, the molecule is the probe for characterizing transport, and the minicomputer is the means of analysis.
INTRAVASCULAR TRANSPORT CHARACTERISTICS
A simple approach to describing large systems is to describe each individual element of the system in terms of a differential operator which defines the input/output relationship. The impulse response of an operator, that is, the response of the element to an infinitely brief pulse input is, for elements of the circulatory system, a function which describes the delay and dispersion between input and output, and describes the deformation imposed on the input to produce the output. No negativity is allowable since concentrations cannot be negative. An alternative to using differential operators is to use a mathematical descriptor with sufficient generality that it can take the shape of the impulse function. The idea is expressed in Fig. 1 .
A convolution integration is a little easier to understand than a differential operator, but in fact represent the same process: each element of the input is considered as a brief pulse with a weight equal to its amplitude, and the output is composed of the sum the impulse outputs, each with its respective weight and delayed and dispersed as defined by the transport function h(t) (8) . When the system is linear and even approximately stationary, then the approach works mathematically, even for the highly oscillatory flow within the aorta (9) . One can in principle always obtain the
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Cout(t t Cout(t) = Cin(t ) * h(t) = IoCin(1;) " h(t-1;)dz impulse response of a linear stationary system by repeatedly adjusting the form of a guessed form of h (t) until the outcome is a correct descriptor, that is, the convolution of the input with the transport function gives a curve which fits the output more or less exactly. How one arrives at this descriptor is theoretically unimportant, unless one wishes to express it in physical or physiological terms. To describe indicator dispersion in the human leg arterial system, we used a unimodal density function whose shaping parameters we could adjust simply, with results as exemplified by Fig. 2 .
The mathematical bases of this approach were previously defined by Zierler (85, 86) and by Gonzalez-Fernandez (35) . There is nothing unique about the lagged normal density curve, for other unimodal density functions will do as well, and useful ones are the gamma variate functions (82), log normal curves (81) a dispersion function (41, 77) or any of several other adjustably shaped right-skewed functions.
Interpreting transport functions in terms of the physics of the system has not been accomplished with the same degree of precision. Such transport functions as derived from the data of Fig. 2 give no information with respect to instantaneous flows or velocity profiles, but rather represent the result of an "effective velocity profile" averaged over several seconds. By making the overly simple assumption that the transport function represents a purely viscous process, then velocity profiles can be calculated algebraically from it. The profiles, in Fig. 3 , show two features that differ from Newtonian flow. The profile is not parabolic, and there is a fine velocity at the wall. The seemingly peculiar pointedness at the center of the stream, at r = 0, may be real, for McDonald (57) by angiography showed extremely pointed profiles in the aorta. Forward spreading due to some turbulence and diffusion may also be (7) with the permission of the American Heart Association.) an explanation, for it produces an early appearance in the leading foot of the dilution curves.
There is no inherent need to describe the transport function with an analytic expression. A numerical description will do, but there are problems with using a simple deconvolution technique to obtain a numerical description, as is suggested by Maseri et al. (59) and further demonstrated by Neufeld (62) ; the dominant problems are that the transport function So obtained is not only highly dependent upon the value of the first points of the observed input and output functions, but also on the time interval used, and on the noisiness of the data curves. I recommend using an integral approach to deconvolution, such as that of Knopp et al. (49) . Their technique was to assume that the transport function could be described in terms of the weighted sum of a family of narrowly dispersed transport functions with a range of mean transit times spread well beyond the physically possible range, and then determining the weighing function by iterative matrix inversion. The result is a transport function that is independent of the nature of the members of the family so long as they are narrow, and is realistically smoothed, so long as the individual transport functions are not exceedingly narrow or approaching a delta function.
FLOW HETEROGENEITY WITHIN ORGANS
So far as I know, there is no organ within which the flow per unit mass of tissue is known to be uniform within a few percent. The brain, kidney, heart, liver and other well studied organs all show substantial heterogeneity. In the heart, flow heterogeneities were recognized by Kirk and Honig (48) , Doutheil and Rhode (29) and ourselves (11, 13, 84) . A basis for it could be seen in the nature of the microvascular network, the maze of 5 micron diameter capillaries that provides nutrient flow to each cardiac cell, a beautiful meshwork explored with one of my closest colleagues, Tada Yipintsoi (14) . However, the extent of the heterogeneity in the normal awake animal was not really appreciated until observations were made repeatedly in awake baboons (46) with microsphere depositions. Perhaps I should say that these observations were not really accepted until the microsphere technique was pretty well vali-dated by comparison of regional flow estimates from the deposition of a "molecular microsphere," desmethylimipramine (21), a lipid soluble solute whose extraction during transorgan passage is virtually complete.
The remarkable degree of heterogeneity, and its just as remarkable stability over long periods of time (47) , suggests that even the heart must have considerable nonuniformity of metabolism and presumably contractile energy expenditure. These suggestions are speculative, but Weiss (83) has noted that there is an association between the abundance of/3-receptors and the oxygen saturation of blood in small venules. This has implications for oxygen exchange (43) and for substrate exchange in general. One observation is that the heterogeneity must be accounted for in order to avoid systematic underestimation of the conductance of the capillary wall to solute passage (18) , the error being 30~ or more with the degree of heterogeneity shown in Fig. 4 . What is needed next is a thorough understanding of the basis for this heterogeneity and consideration of its implications. Are there regions of myocardium which are on the borderline of ischemia in the normal state? Are these the regions which produce lactate during severe exercise or during the infusion of vasopressin in animals (33)?
SOLUTE EXCHANGES DURING TRANSCAPILLARY PASSAGE
Sangren and Sheppard in 1953 (80) developed a single capillary model for bloodtissue exchange that was so pioneering that it had to be rediscovered later. Those who moved the field, Chinard, Renkin, Crone, and Goresky, each developed approaches in the late 1950s and early 1960s which were anticipated by Sangren and Sheppard. Their concept was that the length of the capillary must be accounted for not only to approximate nature, but also to avoid mathematical inconsistencies that occurred with stirred tank modeling, for example the equality of concentrations at inflow and outflow. Their model accounted for concentration gradients along the capillary as material was lost from the blood into the tissue, for a permeability barrier at the capillary wail, and for the return of solute from the extravascular space into the blood stream. It is this last feature that was neglected by Renkin and by Crone, but in fact their approximations were pretty good, and stimulated the field to advance at a rate that the more complete but more complex models could not have done. Actually, we were the first to put the Sangren-Sheppard model to work in terms of actually fitting the data with the model (10, 37, 40) . (Our models also accounted for axial diffusion, but this feature does not have a dramatic influence on the shapes of the curves.)
The first mathematical model that we developed, early in 1965, for transcapillary exchange accounted for axial and radial diffusional concentration gradients as well as the permeability barrier. Though picturesque (12) , it was so cumbersome to compute that adjustments of their parameters to fit tracer dilution curves was totally impractical. The expression which paved the way, originally defined by Christian Bohr (23) and demonstrated as useful by Renkin and by Crone, is:
where PS is the permeability-surface area product of the exchange region, F is flow, and E is the instantaneous fractional extraction compared with a nonextracted intravascular marker. It is still useful, but its major shortcomings, failure to account for either heterogeneity of flow, or the return flux of solute from tissue to blood, lead to underestimation of permeability. Martin and Yudilevich (58) did partial accounting for the return flux by assuming a mixed extravascular region, an approach formalized later by Johnson and Wilson (44) but not used in data analysis.
By 1970, following a pace setting meeting organized by Crone and Lassen (28), our skills and the art of computation was such that model fitting became practical with axial distributed models, which has gradually taken over from the hand calculation methods. You have probably noticed that I have not mentioned compartmental or mixing chamber models, the reasons being that there is no physiological analog for instantaneous mixing pools and data cannot be fitted well using such models (18) .
The model development has continued to 2-and 3-region models of the form shown in Fig. 5 ; all are axially distributed. Nowadays these are incorporated into multicapillary whole organ models, in order to account for the heterogeneity. The approach of Goresky and his colleagues assumes plug flow in all vessels (no dispersion) but a heterogeneity of transit times along parallel pathways, as described by (71) , which is also mass-conservative when the consumption Gpc, is zero. Terms are: Fs, flow ml g 1 rain 1; C, concentration, molar; V', volume of distribution, ml/g; PS, permeabilitysurface area product, ml g-1 rain-l; G, consumption, ml g-1 min 1. Subscripts are: C for capillary; isf for interstitial fluid; pc for parenchymal cell. (Reprinted from Bassingthwaighte, Noodleman, et al. (20) , with permission from Martinus Nijhoff.)
Rose and Goresky (70) . (They have preferred analytical solutions to the differential equations for the models, and have taken advantage of the situation that models without axial diffusion have Laplace representations which allows fitting in the frequency domain rather than the time domain. They obtain good fits to the time domain data by doing so, offsetting my feelings that errors might have been introduced this way.) Our heterogeneity models put the major dispersion in the arteries and veins, as if due to the velocity profile and mixing, and we also allow dispersion within the capillaries (52). Our formulation is thus closer to those of Bronikowski et al. (24) , than to Goresky's, but the differences have not yet been evaluated. Exchange between plasma and erythrocytes is an influence on the exchange with tissue, unless the erythrocyte is impermeable to a solute in the plasma. These effects were explored by Goresky et al. (38) for a condition applicable perhaps only to the liver, low erythrocyte permeability but extremely high tissue cell membrane permeability. Roselli and Harris (74, 75) extended the analysis to account for both capillary and cell membrane barriers, and illustrated that indicator dilution data could be used with substantial sensitivity to evaluate pulmonary capillary and epithelial permeability surface area products. Roselli, Harris and Brigham (76), using a composite intravascular reference curve accounting for the different velocities of red cells and plasma, found that the red cell membrane could be a barrier to exchange of thiourea in the lung capillary. The data of Rose and Goresky (73) on oxygen transport in the dog heart suggested to them that there was a barrier also for 02, but distinction could not be made between the erythrocyte membrane and other barriers between blood and mitochondria. I may be wrong but I have a suspicion their observations may be explained by a diffusion shunt mechanism rather than by a barrier (17) .
I would nevertheless argue that the safest way to analyze multiple indicator dilution curve data where the outflow responses to the injection of several tracers simultaneously into the inflow are acquired, is to fit time-domain solutions to the time-domain data using the weighting scheme that is most appropriate to the errors in the data. This is easier to say now than previously because we have been able to develop the numerical technique used in our 2-region modeling (15) to a state where it is exceedingly fast to compute and apparently more accurate than the analytic solutions, which require convolution integrations. The current state is that 4-region models, such as is shown in Fig. 6 , and 5-region models including red blood cells are readily computable, even on a microcomputer.
These models describe individual capillary-tissue units, which is not sufficient for them to be suitable for the analysis of data. The problem is that data cannot be obtained on a single unit but only on aggregates of units, as with the volume elements defined via high resolution positron emission tomography, or on the whole organ, as with outflow dilution curves. A single capillary-tissue unit would be adequate only if all features of the system were uniform, but they are not.
INFLUENCES OF HETEROGENEITY OF FLOW
Presumably all processes are heterogeneous. Flow heterogeneity in the heart, shown in Fig. 4 , is so great that the estimates show a 6-fold range for the left ventricle alone, and that with a volume resolution of only about 0.2 g of tissue. More refined sectioning would give larger estimates of the variance. Projecting from the observed relationship between the relative dispersion (the coefficient of variation) and the size of the observed tissue samples, on the basis that the system is more or less fractal in nature until the terminal arteriolar bed is reached, suggests that the heterogeneity at the level of sample size of 1 mm 3 woutd be about 40%0 to 50%. The shape of the distribution isn't so predictable, except to say that it is likely right skewed, on the principle that there can be no negative values. Thus it is important to examine the effects of heterogeneity on the exchange processes, for oxygen (43) and substrates.
If one accounts for this heterogeneity alone, assuming all other features of the system to be uniform, then one can determine the approximate magnitude and direction of errors in estimates of parameters of the system. For example, when there is 30070 dispersion in local flows, then analysis of outflow dilution curves obtained for a solute whose capillary permeability is such that the average PS/F is about 1.0 gives 20% underestimates of PS when a single capillary model is used; the error is greater with higher or lower values of PS/F (18) . Errors in other parameters, the volumes of distribution in the interstitial fluid space, or the permeability of the parenchymal cells (sarcolemmal conductance) have different relationships, even opposite in sign for the sarcolemmal PS. There is little reason to believe that the PS products are everywhere constant, except from anatomic evidence.., capillary densities, cell membrane surface areas, and tissue water content are fairly uniform in the heart. However, arguing from the teleological viewpoint that conductances might be proportional to tissue metabolism, and flow likewise, both of which are unproven, one might fit outflow dilution data on a different assumption, namely that PS/F is everywhere constant. Taking the flow heterogeneity as is observed with the deposition of microspheres or of our new molecular microsphere, iododesmethylimipramine (56) , making this assumption gives about a 20~ lower estimate of the average capillary PS for the heart than does making the assumption of PS uniform everywhere. There will be systematic errors in other parameters as well, depending on the true relationship between local flow and local conductances or transport capacities of the membranes. These relationships need to be determined; however, this need not complicate the analysis greatly, if at all, if the relationships are simple ones such as
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These relationships can be simply used in an optimizer program for the analysis, although one or two additional parameters may be required, depending on how consistent the relationship is found to be experimentally.
ANALYSIS OF MULTISPECIES TRACER EXPERIMENTS AND COMPLEX METABOLIC SYSTEMS
Experiments and analyses undertaken in collaboration with other groups of investigators have led us into the complex and interesting problems of accounting for reac-tions that form tracer-labelled products from administered substrates. In a way this is not new, for previous investigators accounted for transformation into products when analyzing tracer dilution curves; the approach was to separate substrate frorrl product in the outflow dilution curves, thereby allowing accounting for substrate only, as was done by Rose and Goresky (71) for palmitate, and Kuikka et al. (52) for glucoses. For some substrates, e.g. adenosine, the appearance of products, inosine and hypoxanthine, is so rapid (39) that they appear within fractions of a second after the substrate has entered the system. Such observations can now be analyzed with multispecies models accounting for the transforming reactions and for the transport across the membranes (45) .
The key to such undertakings is to acquire so much data, with as much precision as possible, that the modeling analysis cannot go wrong. By having many observations, acquired simultaneously on the same experimental preparation, the degrees of freedom in the modeling is greatly reduced. This kind of argument has been made in some detail by Kuikka et al. (52) with respcct to the analysis of glucose transport in the heart. But logical arguments and analytic strategems can go only so far, and the only real security is in the quantity and abundance of the data and the application of the most realistic models to the analysis.
An illustration can be made with respect to the adenosine studies. The experiments have the purpose of determining the transport of adenosine and the products of its metabolism and the rates of transformation in the heart. The experiment was to inject tracer-labelled adenosine into the inflow of an isolated perfused heart, and to collect a sequence of outflow samples at one second intervals for the measurement of adenosine and its products, inosine, hypoxanthine, and uric acid. The measurements are made using HPLC to separate the solutes and tracer counting to quantitate their concentrations in the samples to construct the outflow dilution curves. As in-built controls, tracer-albumin served as an intravascular reference and tracer-AraH, an inert adenosine analog which penetrates interendothelial clefts but doesn't enter cells, served as a matched extracellular marker. Thus there were five simultaneous outflow dilution curves. In addition, the mean flow was known, and the heterogeneity of flow was measured from the deposition of tracer microspheres. The analysis does involve choosing a model for the flow heterogeneity, but there are no free parameters here since the flow distribution and the mean are known. Because the albumin curve defines the intravascular transport, the input function for all the tracers is defined by deconvolution of the albumin curve using the known flow distribution and assuming a uniform intravascular volume in all regions (an assumption which needs verification or modification).
Next the dilution curves are fitted with the multispecies, multiflow model, with a few other constraints. One is that the interstitial space must be identical for all the solutes that permeate the capillary wall, with the most weight given to the AraH data, since it does not enter the cells in any significant amount during the few seconds of the experiment. The input to the inosine model is the transformation reaction (deamination) inside the endothelial cells and myocytes, there being no deaminase in the perfusate or interstitium because of the use of artificial perfusate. It is assumed that the adenosine which is transformed goes into either inosine or into ATP and Sadenosylhomocysteine, both of which are retained, and are therefore indistinguishable except by chemical analysis of tissue samples. The only reaction considered is hydrolysis to hypoxanthine. Hypoxanthine may be transformed to ITP (and thereby retained] or to xanthine and uric acid through the xanthine oxidase/dehydrogenase reactions. For these analyses, no return flux from SAH, ATP, or ITP is considered.
A further constraint is that the values for PSg, the cleft or paracellular permeability, for each of the solutes, adenosine, inosine, hypoxanthine, and uric acid, are held in fixed proportion to that for AraH, the ratios being those of the free diffusion coefficients. Also the volumes of distribution of the free solutes inside and outside the cells (endothelial and myocardial) are presumed equal, on the basis that there are no buffering binding sites and that the reaction sites on the enzymes are in low enough concentration to justify their neglect. The underlying overall constraint is that of mass balance; all tracer entering the system either comes out as one species or another, or is retained in the tissue in one or another form.., the total at the end of the computed solution must equal the integrated input function. Mass balance checking is built into the modeling programs for ease of use and assurance of adequate accuracy in the computation.
LARGE SCALE SYSTEMS OF NON-LINEAR PHYSIOLOGICAL PROCESSES AND BIOCHEMICAL REACTIONS
Extension to larger systems is the natural progression from these small beginnings. Nonlinearity of transport processes and biochemical reactions is expected and commonly demonstrated. Along with carrier-facilitated transport across membranes goes the likelihood of counter transport enhancement (or inhibition) as has been shown for glucose in myocardial cell (61) and for nucleosides in erythrocytes (68) . Such concentration-dependent transport processes add to the computational load, as do concentration-dependent volumes of distribution due to buffering binding sites, and biochemical reactions in general. The adenosine analysis will eventually develop to the stage of accounting for the major ATP-related reactions, as in the modeling developed by Kohn and Garfinkel (50, 51) , where over a dozen species are involved. Likewise, blood-tissue exchange models for fatty acids and glucose must evolve to merge with those of Achs and Garfinkel (1,2), having sufficient complexity to account for a large set of integrated reactions. The techniques for handling even larger systems of biochemical reactions has been greatly advanced in the recent years by the work of Palsson, Lightfoot and colleagues (63) (64) (65) (66) (67) , who have developed techniques for the linearization and approximation of sets of reactions within large systems. Such approaches are important since research in the area will progress much more quickly when model solutions are tractable and computable at speeds fast enough that an investigator can explore the behavior of such systems interactively.
COMPUTATION, OPTIMIZATION, VERIFICATION, AND VALIDATION
I suppose that it is these aspects of the problems which justify this work as being bioengineering rather than traditional physiology. We have to be a bit careful about such statements because physiology has always been considered the quantitative side of biological science, and of course we are not "engineering" the system, merely trying, with engineering approaches and tools, to figure out how it works, and how its working may be improved with interventions in clinical disorders or experimental situations. Computation and optimization of the fitting of models to the data are tools of analysis, allowing the evaluation of the traditional null hypothesis of the scientist.
But these in turn interact with verification and validation, terms used by the simulation community to indicate separate aspects of the work. "Verification" implies that there is a set of tests by which it can be shown that the model simulates what it is supposed to, and that the equations are solved correctly. "Validation" has much deeper implications, namely that the model which expresses the scientific hypothesis has not been disproven, and is therefore valid as a transient working hypothesis for describing the system. Such validation is scale-dependent, for no model can encompass all hierarchical levels of system behavior from the global or macroscopic down to the quantum mechanical level, nor would one be very useful in practical applications if it could.
Most modeling is accomplished within a single hierarchical plane, the elements of the model all being of the same order of size, kinetics, or complexity. But the test of the models often require looking downward a level, to the level providing the explanation for the behavior observed at the current observational level. This is a natural reductionist step. At the same time, other tests of model validation can be developed in the same hierarchical plane as the original hypothesis, by spreading out in the plane, adding same-level components that interact. Often the more demanding tests are in a higher plane. Does the behavior of the subsystems, defined in the plane of the original observations, hold up at the next higher level of integration? For example, does the interplay of chemical reactions involved in cellular energy metabolism provide the correct amount of energy for the known energy-requiring cell functions, and does the system of reactions shift its control points appropriately when stressed?
Each such question is one of model validation. Each test of the hypothesis demands affirmation or denial of the adequacy of the model to fit data. Progress is made when a model does not fit and a next model is developed that does. From our point of view, this means that optimization of the parameters of the model to provide a best fit is a critical tool of the trade. Since any method of optimization is useful if it arrives at a fit of model solution to data, and because general purpose optimizers tend to be slow, even if robust, the development of special purpose optimizers is worthwhile. A particular feature of our Simulation Resource Facility in Circulatory Mass Transport and Exchange, which is closely related to the experimental programs of our University of Washington colleagues and those in other universities, is an effort in developing new optimizers. Some of these turn out to be general, e.g., the sensitivity function approach of Levin et al. (54) , as enhanced more recently (16, 25) , and others more useful for small numbers of parameters than the general routines (22) . Such approaches are as much a part of the trade as fast and accurate numerical techniques.
A NEW PROFESSION: BIOENGINEER, APPLIED MATHEMATICIAN, PHYSIOLOGIST-BIOPHYSICIST-BIOCHEMIST-KINETICIST?
The sets of problems are endless; each new element of physiological knowledge allows us to define a growing set of questions . . . the ignorance explosion. It is important to train biological and medical scientists in this area of endeavor, but it's not at all easy. The difficulty is that training in any one area is not sufficient, but training in all is impossible. Each training arena leaves something to be desired: biochemists and cell biologists are not good at kinetics, physiologists are not welltrained in statistics or even mathematics, mathematicians are not good at evaluating experimental data, especially in biology; and nobody is good at the evaluation of the goodness of fits of models to data, from the point of view of testing compIex hypotheses and discerning the weak points using statistically rational methods not dependent on assumptions of linearity and of Gaussian error. The relationships are basically non-linear, the control systems have no set points, and the parameters of the system are described by right-skewed distributions. A combination of doctoral and postdoctoral training following a good undergraduate training in one of the sciences can be devised to start an investigator on this road, but like all science, it will involve a lifelong learning process.
